Solihull, United Kingdom

Francesca Barone

This inventor holds 1 USPTO granted patent. Top assignee: Sail Biomedicines. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesca Barone. Retrieved from https://idiyas.com/inventor/francesca-barone-6fo988dc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francesca Barone: Patent Activity in Drug Discovery

Introduction

Francesca Barone is an inventor associated with Solihull, Great Britain, and Sail Biomedicines. Her reported patent work concerns compounds designed to inhibit the aryl hydrocarbon receptor (AHR), a target relevant to cancer and immune-related conditions.

Latest Patents

Barone is associated with 1 patent, titled “Pyridopyrimidinone Derivatives as AHR Antagonists.” The disclosure covers pyridopyrimidinone compounds and their pharmaceutically acceptable salts, pharmaceutical compositions, preparation methods, and useful intermediate compounds. It also describes potential methods for preventing or treating diseases, particularly cancer and conditions involving dysregulated immune responses or aberrant AHR signaling. The compounds may also be used alongside at least one additional therapy for cancer.

Career Highlights

The available information connects Barone’s patent activity with Sail Biomedicines. Her listed invention focuses on therapeutic compounds and their potential applications in treating diseases associated with AHR signaling.

Collaborations

Barone’s listed coworkers include Alessandra Bartolozzi and John Robert Proudfoot. Their names are associated with the professional context provided for her patent work.

Conclusion

Francesca Barone’s reported patent contribution centers on AHR-antagonist compounds with potential applications in cancer treatment and disorders involving immune dysregulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…